The influence of diabetes on cardiac β-adrenoceptor subtypes

Heart Failure Reviews

Volumn 12, Issue 1, 2007, Pages 58-65

  Altan, V Melih ^a   Arioglu, Ebru ^a   Guner, Sahika ^a   Ozcelikay, A Tanju ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Adrenoceptor; Diabetes; Gi protein; Gs protein; Heart failure; Sympathetic nervous system

Indexed keywords

ADRENALIN; ALLOXAN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; STREPTOZOCIN;

ADRENERGIC ACTIVITY; ALLOXAN DIABETES MELLITUS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHRONOTROPISM; DIABETES MELLITUS; DISEASE COURSE; HEART ATRIUM; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE WALL; HUMAN; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; GENE EXPRESSION REGULATION; HUMANS; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3;

EID: 34247385437     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-007-9005-6     Document Type: Review

References (81)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular risk factors: The Framingham study. Circulation 59:8-13
2. Solang L, Malmerg K, Ryden L (1999) Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 20:789-795
3. Stone PH, Muller JE, Hartwel T et al (1989) The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 14:49-57
4. Massie BM (2002) Obesity and heart failure risk factor or mechanism. New Eng J Med 347:358-359
5. Sowers JR, Epstein M, Frohlich ED (2001) Diabetes, hypertension and cardiovascular disease: An update. Hypertension 37:1053-1059
6. Swan JV, Walton C, Godsland IF et al (1994) Insulin resistance in chronic heart failure. Eur Heart J 15:1528-1532
7. Rodrigues B, McNeill JH (1992) The diabetic heart: Metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26:913-922
8. Sharma V, McNeill JH (2006) Diabetic cardiomyopathy: Where are we 40 years later? Can J Cardiol 22:305-308
9. Ozturk Y, Altan VM, Yildizoglu-Ari N (1996) Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 48:69-112
10. McNeill JH, Tahiliani AG (1986) Diabetes-induced cardiac changes. Trends Pharmacol Sci 11:364-367
11. Vadlamudi RVSV, McNeill JH (1984) Effect of experimental diabetes on isolated rat heart responsiveness to isoproterenol. Can J Physiol Pharmacol 62:124-131
12. Karasu C, Ozturk Y, Altan N et al (1990) Thyroid hormones-mediated effects of insulin on alloxan diabetic rat atria. Gen Pharmacol 21:735-740
13. Yu Z, McNeill JH (1991) Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy. J Pharmacol Exp Ther 257:64-71
14. Ozuari A, Ozturk Y, Yildizoglu-Ari N et al (1993) The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus. Gen Pharmac 24:165-169
15. Sunderesan PR, Sharma VK, Gingold SL et al (1984) Decreased beta-adrenergic receptors in rat heart in streptozotocin-induced diabetes: Role of thyroid hormones. Endocrinology 114:1358-1363
16. Latifpour J, McNeill JH (1984) Cardiac autonomic receptors: Effect of long-term experimental diabetes. J Pharmacol Exp Ther 230:242-249
17. Atkins FL, Dowell RT, Love S (1985) β-adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in diabetic rat. J Cardiovasc Pharmacol 7:66-70
18. Gando S, Hattori Y, Akaishi Y et al (1997) Impaired contractile response to beta AR stimulation in diabetic rat hearts: Alterations in beta ARs-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 282:475-484
19. Savarese JJ, Berkowitz BA (1979) β-adrenergic receptor decrease in diabetic rat hearts. Life Sci 25:2075-2078
20. Nishio Y, Kashiwagi A, Kida Y et al (1988) Deficiency of cardiac β-adrenergic receptor in streptozotocin-diabetic rats. Diabetes 37:1181-1187
21. Liggett SB (2001) β-adrenergic receptors in the failing heart: The good, the bad and the unknown. J Clin Invest 107:947-948
22. Bristow MR (1998) Why does the myocardium fail? Insights from basic science. Lancet 352(Suppl 1):8-14
23. Post SR, Hammond HK, Insel PA (1999) β-adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 39:341-360
24. Feldman AM, Cates AE, Veazey WB et al (1988) Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82:89-197
25. i-proteins and adenylyl cyclase in heart failure by an ACE inhibitor, imidapril. J Cell Mol Med 7:277-286
26. Ungerer M, Parruti G, Bohm M et al (1994) Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 74:206-213
27. Wilson C, Lincoln C (1984) β-Adrenoceptor subtypes in human, rat, guinea pig and rabbit atria. J Cardiovasc Pharmac 6:1216-1221
28. 3-adrenoreceptors in rat hearts. Diabetes 50:455-461
29. Brodde OE, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651-690
30. 3-adrenergic receptor gene. Mol Pharmacol 44:254-270
31. 2-Adrenoceptors in the human hearth: Properties, function and alterations in chronic heart failure. Pharmacol Rev 43:203-242
32. 2-adrenoceptors mediating contractile responses to β-agonists on the isolated right atrium. Naunyn Schmiedeberg's Arch Pharmacol 332:142-147
33. 3-adrenoceptor in the human heart. J Clin Invest 98:556-562
34. 3-adrenoceptor function in murine heart. Br J Pharmacol 136:217-229
35. Steinberg SF (1999) The molecular basis for distinct β-adrenoceptor subtype actions in cardiomyocytes. Circ Res 85:1101-1111
36. Kaumann AJ, Preitner F, Sarsero D et al (1998) (-) CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol 53:670-675
37. 1-adrenoceptors for putative β4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol 363:87-93
38. 1 -subunit of skeletal muscle L-type Ca channels is the key target for regulation by A-kinase and protein phosphatase-IC. Biochem Biophys Res Commun 198:166-173
39. 2 subunit of L-type voltage-dependent calcium channels. Biochemistry 38:10361-10370
40. Simmerman HK, Jones LR (1998) Phospholamban: Protein structure, mechanism of action and role in cardiac function. Physiol Rev 78:921-947
41. Sulakhe PV, Vo XT (1995) Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli. Mol Cell Biochem 149-150:103-126
42. Marx SO, Reiken S, Hisamatsu Y et al (2000) PKA phosphorylation dissociates FKBPI2.6 from the calcium release channel (ryanodine receptor) defective regulation in failing hearts. Cell 101:365-376
43. Eisner DA, Trafford AW (2002) Heart failure and the ryanodine receptor: does Occam's razor rule? Circ Res 91:979-981
44. 2-adrenergic signaling. J Biol Chem 274:22048-22052
45. 2-adrenergic signal transduction. Circ Res 85:1092-1100
46. Steinberg SF (1999) The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85:1101-1111
47. Zhu WZ, Wang SQ, Chakir K et al (2003) Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 111:617-625
48. Zhu WZ, Zheng M, Koch WJ et al (2001) Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98:1607-1612
49. i-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87:1172-1179
50. Lowell BB, Spiegelman BM (2000) Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660
51. 3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103:1649-1655
52. 3-adrenoceptorstimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102:1377-1384
53. Minneman KP, Hegstrand LR, Molinoff PB (1979) Simultaneous determination of beta-1 and beta-2 adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol 16:34-46
54. Bryan LJ, Cole JJ, O'Donnell SR et al (1981) A study designed to explore the hypothesis that beta-1 adrenoceptors are "innervated receptors" and beta-2 adrenoceptors are "hormonal" receptors. J Pharmacol Exp Ther 216:395-400
55. Wilson C, Lincoln C (1984) β-Adrenoceptor subtypes in human, rat, guinea pig and rabbit atria. J Cardiovasc Pharmac 6:1216-1221
56. Dincer UD, Onay A, Ari N et al (1998) The effects of diabetes on β-adrenoceptors mediated responsiveness of human and rat atria. Diabetes Res Clin Pract 40:113-122
57. Agrawal DK, Bhimji J, McNeill JH (1987) Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J Cardiovasc Pharmac 9:384-393
58. Paulson DJ, Shetlar D, Light KE (1980) Catecholamine levels in the heart, serum and adrenals of experimental diabetic rats. Fed Proc 39:637
59. Christensen NJ (1974) Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes 23:1-8
60. Ganguly PK, Beamish RE, Dhalla KS et al (1987) Norepinephrine storage, distribution and release in diabetic cardiomyopathy. Am J Physiol 252:E734-E739
61. Esler M, Kaye D, Lambert G et al (1997) Adrenergic nervous system in heart failure. Am J Cardiol 80:7L-14L
62. Ganguly PK, Dhalla KS, Innes IR et al (1986) Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res 59:684-693
63. 2 -adrenoceptors in human atrial myocardium. Circ Res 66:1610-1623
64. 2-adrenoceptors in single myocytes from human ventricle. Circulation 88:854-863
65. Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. New Engl J Med 335:1182-1189
66. 2-adrenergic receptors on cardiac myocyte apoptosis. Role of pertussis-toxin sensitive G protein Circulation 100:2210-2212
67. 1-AR mRNA expression in rat heart. Biochem Pharmacol 58:881-885
68. 3-adrenergic receptor. Science 245:1118-1121
69. Arch JRS (2001) The β3-adrenergic system and β3-adrenergic agonists. Rev Endocr Metab Dis 2:385-393
70. 3-Adrenoceptor agonists: Potential, pitfalls and progress. Eur J Pharmacol 440:99-107
71. 3-Adrenoceptors in the cardiovascular system. Trens Pharmacol Sci 21:426-431
72. 3-adrenoceptors. Can J Physiol Pharmacol 78:681-690
73. Bylund DB, Eikenberg DC, Hieble JP et al (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
74. 3-adrenoceptors among other β-adrenoceptor subtypes in the regulation of the cardiovascular system. Arch Mal Coeur 96:905-913
75. 3-adrenoceptor and its regulation in cardiac tissue. Intensivmed 40:484-493
76. 3 -adrenoceptorantagonists in heart failure therapy. Cardiovasc Drug Rev 20:19-26
77. Rozec B, Gauthier C (2006) Beta(3)-adrenoceptors in the cardiovascular system: Putative roles in human pathologies. Pharmacol Ther 111(3):652-673
78. Sakane N, Yashida T, Yoshioka K et al (1997) Beta 3-adrenoreceptor gene polymorphism: A newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes 46:1633-1636
79. Xiu LL, Weng JP, Sui Y et al (2004) Common variants in beta 3-adrenergic-receptor and uncoupling protein-2 genes are associated with type 2 diabetes and obesity. Zhonghua Yi Xue Za Zhi 84:375-379
80. Poornima IG, Parikh P, Shannon RP (2006) Diabetic cardiomyopathy: The search for a unifying hypothesis. Circulation 98:596-605
81. 2+ current in diabetic rat cardiomyocytes. Am J Physiol 274:H1849-H1857